We’re excited to announce that Berkeley Lights and IsoPlexis are moving forward together as PhenomeX, a premier functional cell biology company. Visit Site

Panelists from Genovac, will present case studies of how they have leveraged their core genetic immunization technology and the Beacon optofluidic system to rapidly discover antibodies against challenging targets, such as GPCRs, from a variety of different animal species.

Please fill out the following form to access this resource:

First Name*
Last Name*
Email Address*
Phone Number*
City*
Country*
State*
Company/Institute*
CAPTCHA

Related Resources

View All Resources

Antibody Discovery Beacon System

PRESENTATION: Accessing Broad B Cell Diversity to Rapidly Identify High-value Rabbit Monoclonal Antibodies

Opto® B Discovery on the Beacon® optofluidic system enables rapid selection of lead candidates by function-forward screening of B cells in under 1 week. This presentation will introduce Berkeley Lights’ newest antibody discovery workflow, the Opto® Memory B Discovery workflow, and share how customers are using the workflow to screen rabbit memory B cells to rapidly discover rabbit monoclonal antibodies (as presented at Antibody Engineering & Therapeutics 2023).

Antibody Discovery Beacon System

DATASHEET: Opto® Plasma B Discovery 4.0 Workflow

Recovery of 1,000s of hits from over 40,000 individual plasma B cells in a single 4-chip workflow
Down-selection of lead candidates by functional profiling
Sequencing and re-expression of >1,000 functionally-characterized antibodies

Antibody Discovery

Application Note: Rapidly Discover and Select Potent Ligand/ Receptor Blocking Antibody Lead Candidates with Opto™ Plasma B Discovery

Discover how you can maximize hit recovery and rapidly down-select blocking antibodies from plasma B cells in a single day.